IN8bio, Inc. (INAB) stock
INABNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.82−0.00 (-0.04%)
Close on Nov 13, 2026Market cap $8.08MP/E –Yield –
IN8bio profit margin
Profit margin (net margin) is net income as a percentage of revenue.
No profit margin figures for IN8bio
IN8bio has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?